TENAX THERAPEUTICS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- TENAX THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2020 was $8.66M.
- TENAX THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2018 was $8.91M.
- TENAX THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2014 was $54.91M.
- TENAX THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2012 was $8.00M, a 63.22% increase from fiscal 2011.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2020-12-31 | $8.66M 10-K/A · filed 2021-04-16 | |
| 2018-12-31 | $8.91M 10-K · filed 2020-03-30 | |
| 2014-04-30 | $54.91M 10-K · filed 2017-03-16 | |
| 2012-04-30 | $8.00M 10-K · filed 2013-06-26 | |
| 2011-04-30 | $4.90M 10-K · filed 2012-07-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |